Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, Ethiopia

Background: Highly active anti-retroviral therapy has been reported to be associated with a number of side effects in human immunodeficiency virus patients among which dyslipidemia isa common metabolic disorder. Methods: A Hospital based comparative cross-sectional study among 228 HIV positive patie...

Full description

Bibliographic Details
Main Authors: Anemut Tilahun, Endeshaw Chekol, Awgchew Behaile Teklemaryam, Melaku Mekonnen Agidew, Zelalem Tilahun, Fitalew Tadele Admassu, Nega Dagnaw, Misganaw Asmamaw Mengstie, Alebachew Amsalu, Enyew Fenta Mengistu, Yibeltal Akelew, Tadesse Asmamaw, Berihun Bantie
Format: Article
Language:English
Published: Elsevier 2022-11-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844022026305
_version_ 1798014455006625792
author Anemut Tilahun
Endeshaw Chekol
Awgchew Behaile Teklemaryam
Melaku Mekonnen Agidew
Zelalem Tilahun
Fitalew Tadele Admassu
Nega Dagnaw
Misganaw Asmamaw Mengstie
Alebachew Amsalu
Enyew Fenta Mengistu
Yibeltal Akelew
Tadesse Asmamaw
Berihun Bantie
author_facet Anemut Tilahun
Endeshaw Chekol
Awgchew Behaile Teklemaryam
Melaku Mekonnen Agidew
Zelalem Tilahun
Fitalew Tadele Admassu
Nega Dagnaw
Misganaw Asmamaw Mengstie
Alebachew Amsalu
Enyew Fenta Mengistu
Yibeltal Akelew
Tadesse Asmamaw
Berihun Bantie
author_sort Anemut Tilahun
collection DOAJ
description Background: Highly active anti-retroviral therapy has been reported to be associated with a number of side effects in human immunodeficiency virus patients among which dyslipidemia isa common metabolic disorder. Methods: A Hospital based comparative cross-sectional study among 228 HIV positive patients was conducted from July to August 2020. Socio-demographic and clinical data were collected using structured questionnaires. Fasting venous blood sample was collected and analyzed for Lipid profiles. EDTA sample was analyzed for CD4+ T cell determination. Anthropometric measurement was done. Data were analyzed using SPSS version 22. Independent t-test was done. Logistic and binary regression was done. Result: A total of 228 HIV patients were enrolled in the study. Prevalence of dyslipidemia in HAART naive and HAART treated patients was 61 (53.5%) and 84 (73.7%), respectively. The prevalence of Total Cholesterol ≥200 mg/dl was 50% and 30%; High density lipoprotein cholesterol <40 mg/dl was 43.8% and 36%; Low density lipoprotein cholesterol ≥130 mg/dl was 48.3% and 28.1%; and Triglyceride ≥ 150 mg/dl 59.6% and 39% among HAART treated and HAART naive, respectively. Age greater than 40 years (AOR = 3.27, 95% C.I: 1.47–7.25), blood pressure ≥140/90 (AOR = 16.13, 95% C.I: 5.81–44.75), being on HAART (AOR = 2.73, 95% C.I: 1.35–5.53) and body mass index >25 kg/m2 (AOR = 1.92, 95% C.I: 1.20–4.81) were identified as determinants of dyslipidemia. Conclusion: The mean value of lipid profile was significantly higher among HAART treated as compared to those HAART naive HIV positive clients.
first_indexed 2024-04-11T15:18:34Z
format Article
id doaj.art-d7490ffc3206436baadf94d867f34118
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-11T15:18:34Z
publishDate 2022-11-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-d7490ffc3206436baadf94d867f341182022-12-22T04:16:26ZengElsevierHeliyon2405-84402022-11-01811e11342Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, EthiopiaAnemut Tilahun0Endeshaw Chekol1Awgchew Behaile Teklemaryam2Melaku Mekonnen Agidew3Zelalem Tilahun4Fitalew Tadele Admassu5Nega Dagnaw6Misganaw Asmamaw Mengstie7Alebachew Amsalu8Enyew Fenta Mengistu9Yibeltal Akelew10Tadesse Asmamaw11Berihun Bantie12Department of Biomedical Sciences, College of Health Sciences, Debre Tabor University, Debre Tabor, Ethiopia; Corresponding author.Department of Biomedical Sciences, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaDepartment of Biomedical Sciences, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaDepartment of Biomedical Sciences, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaDepartment of Biomedical Sciences, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaDepartment of Biomedical Sciences, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaDepartment of Biomedical Sciences, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaDepartment of Biomedical Sciences, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaDepartment of Public Health, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaDepartment of Biomedical Sciences, College of Health Sciences, Debre Markos University, Debre Markos, EthiopiaDepartment of Medical Laboratory, College of Health Sciences, Debre Markos University, Debre Markos, EthiopiaDepartment of Biochemistry, College of Health Sciences, Gondar University, Gondar, EthiopiaDepartment of Adult Health Nursing, College of Health Sciences, Debre Tabor University, Debre Tabor, EthiopiaBackground: Highly active anti-retroviral therapy has been reported to be associated with a number of side effects in human immunodeficiency virus patients among which dyslipidemia isa common metabolic disorder. Methods: A Hospital based comparative cross-sectional study among 228 HIV positive patients was conducted from July to August 2020. Socio-demographic and clinical data were collected using structured questionnaires. Fasting venous blood sample was collected and analyzed for Lipid profiles. EDTA sample was analyzed for CD4+ T cell determination. Anthropometric measurement was done. Data were analyzed using SPSS version 22. Independent t-test was done. Logistic and binary regression was done. Result: A total of 228 HIV patients were enrolled in the study. Prevalence of dyslipidemia in HAART naive and HAART treated patients was 61 (53.5%) and 84 (73.7%), respectively. The prevalence of Total Cholesterol ≥200 mg/dl was 50% and 30%; High density lipoprotein cholesterol <40 mg/dl was 43.8% and 36%; Low density lipoprotein cholesterol ≥130 mg/dl was 48.3% and 28.1%; and Triglyceride ≥ 150 mg/dl 59.6% and 39% among HAART treated and HAART naive, respectively. Age greater than 40 years (AOR = 3.27, 95% C.I: 1.47–7.25), blood pressure ≥140/90 (AOR = 16.13, 95% C.I: 5.81–44.75), being on HAART (AOR = 2.73, 95% C.I: 1.35–5.53) and body mass index >25 kg/m2 (AOR = 1.92, 95% C.I: 1.20–4.81) were identified as determinants of dyslipidemia. Conclusion: The mean value of lipid profile was significantly higher among HAART treated as compared to those HAART naive HIV positive clients.http://www.sciencedirect.com/science/article/pii/S2405844022026305DyslipidemiaHAARTHIV/AIDSDebre TaborEthiopia
spellingShingle Anemut Tilahun
Endeshaw Chekol
Awgchew Behaile Teklemaryam
Melaku Mekonnen Agidew
Zelalem Tilahun
Fitalew Tadele Admassu
Nega Dagnaw
Misganaw Asmamaw Mengstie
Alebachew Amsalu
Enyew Fenta Mengistu
Yibeltal Akelew
Tadesse Asmamaw
Berihun Bantie
Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, Ethiopia
Heliyon
Dyslipidemia
HAART
HIV/AIDS
Debre Tabor
Ethiopia
title Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, Ethiopia
title_full Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, Ethiopia
title_fullStr Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, Ethiopia
title_full_unstemmed Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, Ethiopia
title_short Prevalence and predictors of dyslipidemia among HAART treated and HAART naive HIV positive clients attending Debre Tabor Hospital, Debre Tabor, Ethiopia
title_sort prevalence and predictors of dyslipidemia among haart treated and haart naive hiv positive clients attending debre tabor hospital debre tabor ethiopia
topic Dyslipidemia
HAART
HIV/AIDS
Debre Tabor
Ethiopia
url http://www.sciencedirect.com/science/article/pii/S2405844022026305
work_keys_str_mv AT anemuttilahun prevalenceandpredictorsofdyslipidemiaamonghaarttreatedandhaartnaivehivpositiveclientsattendingdebretaborhospitaldebretaborethiopia
AT endeshawchekol prevalenceandpredictorsofdyslipidemiaamonghaarttreatedandhaartnaivehivpositiveclientsattendingdebretaborhospitaldebretaborethiopia
AT awgchewbehaileteklemaryam prevalenceandpredictorsofdyslipidemiaamonghaarttreatedandhaartnaivehivpositiveclientsattendingdebretaborhospitaldebretaborethiopia
AT melakumekonnenagidew prevalenceandpredictorsofdyslipidemiaamonghaarttreatedandhaartnaivehivpositiveclientsattendingdebretaborhospitaldebretaborethiopia
AT zelalemtilahun prevalenceandpredictorsofdyslipidemiaamonghaarttreatedandhaartnaivehivpositiveclientsattendingdebretaborhospitaldebretaborethiopia
AT fitalewtadeleadmassu prevalenceandpredictorsofdyslipidemiaamonghaarttreatedandhaartnaivehivpositiveclientsattendingdebretaborhospitaldebretaborethiopia
AT negadagnaw prevalenceandpredictorsofdyslipidemiaamonghaarttreatedandhaartnaivehivpositiveclientsattendingdebretaborhospitaldebretaborethiopia
AT misganawasmamawmengstie prevalenceandpredictorsofdyslipidemiaamonghaarttreatedandhaartnaivehivpositiveclientsattendingdebretaborhospitaldebretaborethiopia
AT alebachewamsalu prevalenceandpredictorsofdyslipidemiaamonghaarttreatedandhaartnaivehivpositiveclientsattendingdebretaborhospitaldebretaborethiopia
AT enyewfentamengistu prevalenceandpredictorsofdyslipidemiaamonghaarttreatedandhaartnaivehivpositiveclientsattendingdebretaborhospitaldebretaborethiopia
AT yibeltalakelew prevalenceandpredictorsofdyslipidemiaamonghaarttreatedandhaartnaivehivpositiveclientsattendingdebretaborhospitaldebretaborethiopia
AT tadesseasmamaw prevalenceandpredictorsofdyslipidemiaamonghaarttreatedandhaartnaivehivpositiveclientsattendingdebretaborhospitaldebretaborethiopia
AT berihunbantie prevalenceandpredictorsofdyslipidemiaamonghaarttreatedandhaartnaivehivpositiveclientsattendingdebretaborhospitaldebretaborethiopia